Fig. 1
From: Deamidation-related blood biomarkers show promise for early diagnostics of neurodegeneration
Validating the deamidation biomarkers in differentiating AD vs Control. a-c IsoAsp levels in HSA are increased (a), and the anti-aHSA IgG levels are decreased in AD compared to Control (b); the isoAsp/anti-aHSA IgG ratios are also different (c). The ROC curves for differentiating AD and controls by (d) isoAsp in HSA, anti-aHSA IgG and isoAsp/anti-aHSA IgG ratio. (e) The comparison of AUCs of all blood biomarkers